Clinical usefulness of urinary liver-type fatty acid binding protein as a marker of chronic kidney disease in patients undergoing open abdominal aortic aneurysm repair

Clinical usefulness of urinary liver-type fatty acid binding protein as a marker of chronic kidney disease in patients undergoing open abdominal aortic aneurysm repair - Clinical usefulness of a biomarker of chronic kidney disease in patients undergoing open abdominal aortic aneurysm repair

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026215

Enrollment

Registered

2019-02-20

Start date

2016-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
postoperative CKD	—

Countries

Japan

Contacts

Public ContactYumi Obata

St Mariannna University School of Medicine Anesthesiology

y2obata@marianna-u.ac.jp044-977-8111

Outcome results